Venture

SV Life Sciences Fund IV CF, L.P.

Sold $421M 2022-03-25

Venture Capital Fund

  • CIK 1877185
  • File 021-438954
  • State MA
  • 506(b)
  • 3(c)(1)
Sought
$421M
Form D target
Sold so far
$421M
100% of sought · 2022-03-25
Investors
44
reported
Minimum investment
$0
no minimum, as filed

Connected

from Form D 021-438954

Fund size — sought vs sold

$421M of $421M
$421M sold · 100%$421M sought

Facts

As its latest Form D states them

Fund type
Venture Capital Fund
Adviser (attributed)
None attributed
State
Massachusetts (MA)
Exemptions
Rule 506(b); Investment Company Act Section 3(c)(1)
First filed
2022-03-25
Latest filing
2022-03-25
First sale
2021-08-13
Filings
1 Form D

People

Named in Item 3 of its latest Form D, filed 2022-03-25

Related persons
NameRelationshipClarification
SV Life Sciences Fund IV CF (GP), LLCRelationshipExecutive OfficerClarificationGeneral Partner of the Issuer
Kate BinghamRelationshipExecutive OfficerClarification—
Greg MaddenRelationshipExecutive OfficerClarification—
Thomas FlynnRelationshipExecutive OfficerClarification—
Eugene HillRelationshipExecutive OfficerClarification—
Paul LaVioletteRelationshipExecutive OfficerClarification—
Michael RossRelationshipExecutive OfficerClarification—
Houman AshrafianRelationshipExecutive OfficerClarification—
Michael BalmuthRelationshipExecutive OfficerClarification—

History

  • 2022-03-25Form D filed · 021-438954
The firm behind it, its other funds, and every Form D as filedSee plans

A fund's Form D states its target and what it has sold so far. The dashboard puts it beside the adviser's other funds from Form ADV, the startups linked to it, and every amendment as filed.

  • The adviser's Venture page: its Form ADV funds, assets and other Form D offerings
  • Where co-filings link it, the startups this fund backed
  • Every Form D and amendment as filed, with what each one stated
  • Everyone its filings name, linked to their other funds and companies

Part of the Venture plan — $140/mo at launch pricing ($350 list)

See plans

External link: SEC Filings ↗